- JP-listed companies
- J-Pharma Co.,Ltd.
- Cash flow
J-Pharma Co.,Ltd. (520A) Cash flow
Market cap
¥7.7B
P/E ratio
-2.7x
J-Pharma develops innovative small-molecule drugs targeting LAT1 transporters to treat cancer and autoimmune diseases with novel mechanisms of action.
| 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 2 | 0 | 1 |
| Cash from operations | -1,411 | -1,695 | -2,249 |
| Capital expenditures | -2 | -0 | -4 |
| Cash from investing | -30 | -0 | -4 |
| Cash from financing | 925 | 2,924 | 4,334 |